Drug Trial Radar · NCT03900325
Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Exploratory Efficacy of Nimacimab in Patients With Diabetic Gastroparesis
Last checked: Nov 19, 2026Latest source record: Jan 18, 2020 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
6
Actual
Start
Aug 1, 2019
Primary completion
Jan 2020
Study completion Apr 2020
Sponsor
- Lead sponsor
- Bird Rock Bio, Inc.Industry
- Sponsor type
- Industry
- First posted
- Apr 3, 2019
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Non randomized
- Model
- Sequential
- Masking
- Single (participant)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 70 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a single blind phase 2a study to evaluate the safety, tolerability, pharmacokinetics, and exploratory efficacy of nimacimab in patients with diabetic gastroparesis.
Conditions
- Diabetic Gastroparesis
Interventions
NimacimabDrug
2.5 mg/kg
PlaceboDrug
0.9% sodium chloride
Primary outcomes
What the sponsor says the trial is designed to measure.
- Frequency of clinically significant laboratory abnormalitiesTime frame: Day 38
- Frequency of clinically significant vital signsTime frame: Day 38
- Frequency of clinically significant ECGsTime frame: Day 38
Locations
5 sites in 1 country. Site status is shown where the registry gives one.
Panax Clinical Research
Miami, Florida
International Research Associates, LLC
Miami, Florida
PRN of Kansas
Wichita, Kansas
Mayo Clinic
Rochester, Minnesota
ClinSearch
Chattanooga, Tennessee
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.